ES8609364A1 - Procedimiento de preparar derivados antihipertensivos - Google Patents
Procedimiento de preparar derivados antihipertensivosInfo
- Publication number
- ES8609364A1 ES8609364A1 ES546866A ES546866A ES8609364A1 ES 8609364 A1 ES8609364 A1 ES 8609364A1 ES 546866 A ES546866 A ES 546866A ES 546866 A ES546866 A ES 546866A ES 8609364 A1 ES8609364 A1 ES 8609364A1
- Authority
- ES
- Spain
- Prior art keywords
- antihypertensive
- derivatives
- substituents
- chem
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000003276 anti-hypertensive effect Effects 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/649,797 US4746676A (en) | 1984-09-12 | 1984-09-12 | Carboxyalkyl dipeptide compounds |
| US06/752,695 US4749698A (en) | 1985-07-08 | 1985-07-08 | Antihypertensive derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8609364A1 true ES8609364A1 (es) | 1986-07-16 |
| ES546866A0 ES546866A0 (es) | 1986-07-16 |
Family
ID=27095707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES546866A Expired ES8609364A1 (es) | 1984-09-12 | 1985-09-11 | Procedimiento de preparar derivados antihipertensivos |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0175266B1 (cg-RX-API-DMAC7.html) |
| KR (1) | KR860002464A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE135711T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU578489B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA1288893C (cg-RX-API-DMAC7.html) |
| DE (1) | DE3588094T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK412985A (cg-RX-API-DMAC7.html) |
| ES (1) | ES8609364A1 (cg-RX-API-DMAC7.html) |
| FI (1) | FI89716C (cg-RX-API-DMAC7.html) |
| IL (1) | IL76345A (cg-RX-API-DMAC7.html) |
| IN (1) | IN164615B (cg-RX-API-DMAC7.html) |
| NO (1) | NO169442C (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ213432A (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5629345A (en) * | 1993-07-23 | 1997-05-13 | Vide Pharmaceuticals | Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure |
| US5965620A (en) * | 1993-07-23 | 1999-10-12 | Vide Pharmaceuticals | Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure |
| EP0765341A4 (en) * | 1994-06-16 | 1998-09-16 | Smithkline Beecham Corp | CYCLISATION DIRECTED BY MATRIX |
| EP1227805B2 (en) † | 1999-10-14 | 2011-02-23 | Curis, Inc. | Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| ES2346399T3 (es) | 2000-09-21 | 2010-10-15 | Abb Schweiz Ag | Configuracion de un sistema de control de una instalacion electrica. |
| PT1966130E (pt) | 2005-12-23 | 2014-01-30 | Zealand Pharma As | Compostos miméticos de lisina modificados |
| US20080188545A1 (en) | 2006-12-21 | 2008-08-07 | Alimardanov Asaf R | Synthesis of pyrrolidine compounds |
| WO2018202865A1 (en) | 2017-05-05 | 2018-11-08 | Zealand Pharma A/S | Gap junction intercellular communication modulators and their use for the treatment of diabetic eye disease |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5683483A (en) * | 1979-12-13 | 1981-07-08 | Santen Pharmaceut Co Ltd | Thiazolidine compound |
| US4350704A (en) * | 1980-10-06 | 1982-09-21 | Warner-Lambert Company | Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids |
| GR75019B (cg-RX-API-DMAC7.html) * | 1980-09-17 | 1984-07-12 | Univ Miami | |
| US4462943A (en) * | 1980-11-24 | 1984-07-31 | E. R. Squibb & Sons, Inc. | Carboxyalkyl amino acid derivatives of various substituted prolines |
| FR2501399B1 (fr) * | 1981-03-03 | 1987-06-19 | France Etat | Dispositif d'affichage de messages graphiques transmis par des systemes de videotex |
| EP0080822A1 (en) * | 1981-11-27 | 1983-06-08 | Beecham Group Plc | Anti-hypertensive prolinol-based peptides |
| EP0088350B1 (en) * | 1982-03-08 | 1985-02-20 | Schering Corporation | Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them |
| CA1258853A (en) * | 1982-04-30 | 1989-08-29 | Rudiger D. Haugwitz | Substituted 4-phenoxy prolines |
| AU1643283A (en) * | 1982-07-19 | 1984-01-26 | E.R. Squibb & Sons, Inc. | Substituted peptides |
| US4623729A (en) * | 1982-07-22 | 1986-11-18 | E. R. Squibb & Sons, Inc. | Acylalkylaminocarbonyl substituted amino and imino acid compounds |
| US4499079A (en) * | 1982-11-18 | 1985-02-12 | E. R. Squibb & Sons, Inc. | Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides |
| DK156484A (da) * | 1983-03-16 | 1984-09-17 | Usv Pharma Corp | Aminosyrederivater |
| AU2859984A (en) * | 1983-05-23 | 1984-11-29 | Usv Pharmaceutical Corp. | Compounds for treating hypertension |
-
1985
- 1985-09-10 EP EP85111454A patent/EP0175266B1/en not_active Expired - Lifetime
- 1985-09-10 AT AT85111454T patent/ATE135711T1/de not_active IP Right Cessation
- 1985-09-10 IL IL76345A patent/IL76345A/xx unknown
- 1985-09-10 DE DE3588094T patent/DE3588094T2/de not_active Expired - Fee Related
- 1985-09-10 AU AU47331/85A patent/AU578489B2/en not_active Ceased
- 1985-09-11 NZ NZ213432A patent/NZ213432A/xx unknown
- 1985-09-11 DK DK412985A patent/DK412985A/da not_active Application Discontinuation
- 1985-09-11 ES ES546866A patent/ES8609364A1/es not_active Expired
- 1985-09-11 CA CA000490437A patent/CA1288893C/en not_active Expired - Lifetime
- 1985-09-11 NO NO853551A patent/NO169442C/no unknown
- 1985-09-11 KR KR1019850006633A patent/KR860002464A/ko not_active Ceased
- 1985-09-12 FI FI853494A patent/FI89716C/fi not_active IP Right Cessation
- 1985-09-16 IN IN652/CAL/85A patent/IN164615B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI89716B (fi) | 1993-07-30 |
| DK412985D0 (da) | 1985-09-11 |
| FI89716C (fi) | 1993-11-10 |
| DE3588094T2 (de) | 1996-08-22 |
| FI853494L (fi) | 1986-03-13 |
| DK412985A (da) | 1986-03-13 |
| FI853494A0 (fi) | 1985-09-12 |
| IL76345A0 (en) | 1986-01-31 |
| ATE135711T1 (de) | 1996-04-15 |
| NO169442C (no) | 1992-06-24 |
| DE3588094D1 (de) | 1996-04-25 |
| NZ213432A (en) | 1988-11-29 |
| ES546866A0 (es) | 1986-07-16 |
| NO169442B (no) | 1992-03-16 |
| AU4733185A (en) | 1986-03-20 |
| EP0175266B1 (en) | 1996-03-20 |
| NO853551L (no) | 1986-03-13 |
| KR860002464A (ko) | 1986-04-26 |
| EP0175266A3 (en) | 1988-08-03 |
| CA1288893C (en) | 1991-09-10 |
| AU578489B2 (en) | 1988-10-27 |
| EP0175266A2 (en) | 1986-03-26 |
| IN164615B (cg-RX-API-DMAC7.html) | 1989-04-22 |
| IL76345A (en) | 1988-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE75743T1 (de) | Hydrazinderivate und ihre verwendung. | |
| CA1271747C (en) | BENZAZEPINE DERIVATIVES | |
| DE3585817D1 (de) | N-substituierte triazol-derivate, ihre herstellung und ihre verwendung. | |
| ES8609364A1 (es) | Procedimiento de preparar derivados antihipertensivos | |
| EP0121830A3 (en) | Substituted dipeptides as antihypertensives | |
| AU574806B2 (en) | 2,2,6,6 - tetramethyl - 4 - piperidinyl derivatives | |
| ES8602021A1 (es) | Procedimiento de preparar compuestos espirociclicos antihi- pertensivos | |
| CA1271748C (en) | BENZAZEPINE DERIVATIVES | |
| IT8521235A0 (it) | Composti farmacologicamente attivi. | |
| FI893212L (fi) | Antihypertensiva aminoalkylaminokarbo- nylaminodiolaminsyraderivat. | |
| DE3585315D1 (de) | 5,6,7,8-tetrafluoranthrachinonderivate. | |
| GB8605551D0 (en) | 4-amino-6,7-dimethoxy-2-piperazin-1-ylquinazoline derivatives | |
| CA1265131C (en) | ERYTHROMYCYLAMINE DERIVATIVES | |
| FI850197A0 (fi) | Foerfarande foer kontroll av byggdelar med hjaelp av en virvelstroem, i synnerhet i kaerntekniska anlaeggningar. | |
| FI861951A7 (fi) | 1,3-oxatianderivat. | |
| ES8606874A1 (es) | Metodo de preparacion de compuestos espiroamidoamino anti- hipertensivos | |
| EP0127090A3 (en) | Angiotensin-converting enzyme inhibitors | |
| EP0153755A3 (en) | Compounds for treating hypertension | |
| GR852224B (cg-RX-API-DMAC7.html) | ||
| AU4004085A (en) | 3-mercapto-1,2,4-triazacycloalkadiene derivatives | |
| SU1132513A1 (ru) | 2-метиламино-4-оксо-3,6,6-триметил-5,6-дигидро-8н-пирано[4′,3′ : 4,5]тиено[2,3-d]пиримидин или его соли, обладающие противосудорожной активностью | |
| FI853584A7 (fi) | Menetelmä farmaseuttisesti aktiivisten 1,4-dihydropyridiinien valmistamiseksi. | |
| IT8433319V0 (it) | Spiralex maxima securitas 2000 n. 5cu 285,70 mg | |
| SU1610823A1 (ru) | S-трет-бутилтиуронийбромид, обладающий антиишемической активностью | |
| NO862648L (no) | Framgangsmÿte for framstilling av farmakologisk aktive 2-substituerte-3,4-dihydroksyfenyletylamino-derivater. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19981001 |